# FDA recall D-1836-2019

> **Upsher Smith Laboratories, Inc.** · Class II · drug recall initiated 2019-07-29.

## Product

Bexarotene Capsules, 75 mg, 100 capsules per bottle, Rx Only, Manufactured for: Upsher-Smith Laboratories, LLC, Maple Grove, MN 55369.  NDC: 0832-0285-00

## Reason for recall

Failed Dissolution Specifications

## Distribution

KY, OH, NJ, LA

## Key facts

- **Recall number:** D-1836-2019
- **Recalling firm:** Upsher Smith Laboratories, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-07-29
- **Report date:** 2019-08-28
- **Termination date:** 2022-08-25

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Maple Grove, MN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1836-2019

## Citation

> AI Analytics. FDA recall D-1836-2019. Retrieved 2026-07-18 from https://api.ai-analytics.org/recall/D-1836-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*